TG-4023

N/A

Report date: 2023/10/26 16:04:10

Base Information

Drug NameTG-4023

Drug Alias NameAd-FCU1TG-4023MVA-FCU1

ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adenoviral vector

Mechanisms of ActionGene transference

TargetsNot applicable

Therapy Area/IndicationsCarcinoma, Hepatocellular

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesTransgene Sa

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesTransgene Sa

Active IndicationsN/A

Inactive IndicationsCarcinoma, Hepatocellular

ATC CodeN/A